Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
INVASIVE THYMOMA - TREATMENT WITH POSTOPERATIVE RADIATION-THERAPY
Autore:
LATZ D; SCHRAUBE P; OPPITZ U; KUGLER C; MANEGOLD C; FLENTJE M; WANNENMACHER MF;
Indirizzi:
UNIV HEIDELBERG,DEPT RADIOTHERAPY,NEUENHEIMER FELD 400 D-69120 HEIDELBERG GERMANY THORAX HOSP HEIDELBERG GERMANY UNIV WURZBURG,DEPT RADIOTHERAPY D-97070 WURZBURG GERMANY
Titolo Testata:
Radiology
fascicolo: 3, volume: 204, anno: 1997,
pagine: 859 - 864
SICI:
0033-8419(1997)204:3<859:IT-TWP>2.0.ZU;2-T
Fonte:
ISI
Lingua:
ENG
Soggetto:
COMPLETE RESECTION; MALIGNANT THYMOMA; CLINICAL STAGES; PROGNOSIS; CHEMOTHERAPY; FEATURES; RADIOTHERAPY; IRRADIATION; EXPERIENCE;
Keywords:
CHEMOTHERAPY; THERAPEUTIC RADIOLOGY, POSTOPERATIVE; THYMUS, NEOPLASMS; THYMUS, THERAPEUTIC RADIOLOGY;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
34
Recensione:
Indirizzi per estratti:
Citazione:
D. Latz et al., "INVASIVE THYMOMA - TREATMENT WITH POSTOPERATIVE RADIATION-THERAPY", Radiology, 204(3), 1997, pp. 859-864

Abstract

PURPOSE: To assess radiation therapy and chemotherapy in the treatment of invasive thymoma and thymic carcinoma. MATERIALS AND METHODS: In 1981-1995, 43 patients received irradiation after total (n = 23) or subtotal (n = 20) resection. Tumors were thymic carcinoma (n = 10) or invasive thymoma (n = 33). Masaoka stage was II in 10 patients, III in 14, and IV in 19. Median total dose applied was 50 Gy (range, 10-72 Gy). Seventeen patients (five with stage III and 12 with stage IV) also received chemotherapy. RESULTS: Patients with thymic carcinoma had a median survival of 9.5 months, compared with 50 months Tor patients withinvasive thymoma (P = .008). Patients' median survival and 5-year survival rates were 97 months and 90% for stage II, 65 months and 67% forstage III, and 32.5 months and 30% for stage IV tumors (P = .024). Overall control rate within the radiation field was 81% (35 patients) and overall local control rate within the thorax was 74% (32 patients). Of the 17 patients who received chemotherapy and radiation therapy, nine had thymic carcinoma and a median survival of 12 months (range, 1.4-23.0 months). CONCLUSION: With total doses of 45-50 Gy, local controlis achievable after radical resection. Whether patients with completely resected stage II thymomas should receive radiation after surgery remains uncertain, as does the role of chemotherapy in the treatment ofthymoma.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/12/20 alle ore 19:43:30